Literature DB >> 28226198

Olanzapine-induced early cardiovascular effects are mediated by the biological clock and prevented by melatonin.

Francisco Romo-Nava1,2,3, Frederik N Buijs1,4, Marcela Valdés-Tovar5, Gloria Benítez-King5, MariCarmen Basualdo1, Mercedes Perusquía6, Gerhard Heinze2, Carolina Escobar7, Ruud M Buijs1.   

Abstract

Second generation antipsychotics (SGA) are associated with adverse cardiometabolic side effects contributing to premature mortality in patients. While mechanisms mediating these cardiometabolic side effects remain poorly understood, three independent studies recently demonstrated that melatonin was protective against cardiometabolic risk in SGA-treated patients. As one of the main target areas of circulating melatonin in the brain is the suprachiasmatic nucleus (SCN), we hypothesized that the SCN is involved in SGA-induced early cardiovascular effects in Wistar rats. We evaluated the acute effects of olanzapine and melatonin in the biological clock, paraventricular nucleus and autonomic nervous system using immunohistochemistry, invasive cardiovascular measurements, and Western blot. Olanzapine induced c-Fos immunoreactivity in the SCN followed by the paraventricular nucleus and dorsal motor nucleus of the vagus indicating a potent induction of parasympathetic tone. The involvement of a SCN-parasympathetic neuronal pathway after olanzapine administration was further documented using cholera toxin-B retrograde tracing and vasoactive intestinal peptide immunohistochemistry. Olanzapine-induced decrease in blood pressure and heart rate confirmed this. Melatonin abolished olanzapine-induced SCN c-Fos immunoreactivity, including the parasympathetic pathway and cardiovascular effects while brain areas associated with olanzapine beneficial effects including the striatum, ventral tegmental area, and nucleus accumbens remained activated. In the SCN, olanzapine phosphorylated the GSK-3β, a regulator of clock activity, which melatonin prevented. Bilateral lesions of the SCN prevented the effects of olanzapine on parasympathetic activity. Collectively, results demonstrate the SCN as a key region mediating the early effects of olanzapine on cardiovascular function and show melatonin has opposing and potentially protective effects warranting additional investigation.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  blood pressure; cardiovascular; melatonin; olanzapine; suprachiasmatic nucleus

Mesh:

Substances:

Year:  2017        PMID: 28226198     DOI: 10.1111/jpi.12402

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  5 in total

Review 1.  Potential Role of Melatonin as an Adjuvant for Atherosclerotic Carotid Arterial Stenosis.

Authors:  Rui Zhang; Leng Ni; Xiao Di; Baitao Ma; Shuai Niu; Zhihua Rong; Changwei Liu
Journal:  Molecules       Date:  2021-02-04       Impact factor: 4.411

2.  Melatonin Suppresses Ferroptosis Induced by High Glucose via Activation of the Nrf2/HO-1 Signaling Pathway in Type 2 Diabetic Osteoporosis.

Authors:  Hongdong Ma; Xindong Wang; Weilin Zhang; Haitian Li; Wei Zhao; Jun Sun; Maowei Yang
Journal:  Oxid Med Cell Longev       Date:  2020-12-04       Impact factor: 6.543

3.  Antipsychotic-induced weight gain and metabolic effects show diurnal dependence and are reversible with time restricted feeding.

Authors:  Rizaldy C Zapata; Allison Silver; Dongmin Yoon; Besma Chaudry; Avraham Libster; Michael J McCarthy; Olivia Osborn
Journal:  Schizophrenia (Heidelb)       Date:  2022-08-30

Review 4.  A matter of time: A systematic scoping review on a potential role of the circadian system in binge eating behavior.

Authors:  Francisco Romo-Nava; Anna I Guerdjikova; Nicole N Mori; Frank A J L Scheer; Helen J Burgess; Robert K McNamara; Jeffrey A Welge; Carlos M Grilo; Susan L McElroy
Journal:  Front Nutr       Date:  2022-09-08

5.  The Protective Effects of Melatonin Against LPS-Induced Septic Myocardial Injury: A Potential Role of AMPK-Mediated Autophagy.

Authors:  Shouyin Di; Zheng Wang; Wei Hu; Xiaolong Yan; Zhiqiang Ma; Xiaofei Li; Weimiao Li; Jianyuan Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-16       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.